Live Evaluations
ADCS Advanced Therapeutic Update: June 11, 2024
About
Advanced Therapeutic Update CME Session
Tuesday, June 11, 2024
8 PM ET / 5 PM PT
Part I: From Patchy to Precise: Enhancing Alopecia Areata Management High Risk Cutaneous SCC: Staging and Treating
Part II: High Risk Cutaneous SCC: Staging and Treating
Learning Objectives
At the completion of this activity, participants should be better able to:
Recognize the two key trichoscopy findings of alopecia areata
Evaluate when and how to incorporate oral minoxidil, pulsed dexamethasone, and oral JAK inhibitors in advanced cases of alopecia areata
Identify which SCC tumors are defined as ‘high risk’
Discuss with patients why their tumor may need more than just surgery
Implement management strategies to more closely monitor patients with high risk SCC
Intended Audience
Faculty
Spencer Hawkins, MD, FAAD
Double Board-Certified Dermatologist
Mohs Micrographic Surgeon
Advanced Dermatology and Cosmetic Surgery
East Greenwich, RI
Mark Kaufmann, MD
Chief Medical Officer, Advanced Dermatology and Cosmetic Surgery
Clinical Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Juan-Carlos Martinez, MD
Mohs Micrographic Surgery Specialist
Advanced Dermatology and Cosmetic Surgery
Jacksonville Beach, FL
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board/Consultant: Voluntus
Employee/Owner: Owner of Hair Medicine Institute, LLC
Consultant: Apogee Therapeutics, Avita Medical, Biofrontera, Dermagnostix, Dermtech,Incyte, Novan, Novartis, Rise Healthcare, Rivera Consulting, UCB, Verrica
Ownership Interest (privately held): Modernizing Medicine, Molesafe
No relevant financial relationships with any Ineligible Company in the past 24 months.
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.